# clm_8425BCAEBDE4

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 2,150,900,000 United States dollar  
valid_from: 2010-06-30  
valid_to: 2010-09-30  
published: 2010-08-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_CB134DA21407  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 2,150,900,000 United States dollar", as of 2010-06-30 (until 2010-09-30). Claim clm_8425BCAEBDE4, https://asof.is/claim/clm_8425BCAEBDE4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2010, filed 2010-08-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm (primary, SEC EDGAR 10-Q Q2 FY2010, published 2010-08-06)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 2,026,700,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_8425BCAEBDE4](/claim/clm_8425BCAEBDE4.md) | [clm_49575E9AC377](/claim/clm_49575E9AC377.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.